publication venue for
- 10(th) Congress on Lung Cancer-updates on clinical trials: goal. 66-69. 2015
- Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients. 491-497. 2013
- Cisplatin plus vinorelbine as first-line treatment for advanced non-small-cell lung cancer: Is a hemogram on day 8 essential?. 415-419. 2013
- First-line therapy and methylation status of CHFR in serum influence outcome to chemotherapy versus EGFR tyrosine kinase inhibitors as second-line therapy in stage IV non-small-cell lung cancer patients. 84-91. 2013
- Lung cancer and treatment in elderly patients: the Achilles Study. 103-106. 2013
- Randomized phase II trial of non-platinum induction or consolidation chemotherapy plus concomitant chemoradiation in stage III NSCLC patients: Mature results of the Spanish Lung Cancer Group 0008 study.. 84-91. 2013
- Trabectedin in patients with advanced non-small-cell lung cancer (NSCLC) with XPG and/or ERCC1 overexpression and BRCA1 underexpression and pretreated with platinum. 354-361. 2013
- Three-week schedule of irinotecan and cisplatin in advanced non-small cell lung cancer: a multicentre phase II study. 201-207. 2003
- CEA and CA 549 in serum and pleural fluid of patients with pleural effusion.. 83-89. 2002
- Organizing pneumonia adjacent to lung cancer. Frequency and clinicopathologic characteristics.. 195-201. 2002